123 related articles for article (PubMed ID: 25553984)
1. Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.
Liang Z; Sun XY; Xu LC; Fu RZ
Med Sci Monit; 2014 Dec; 20():2776-82. PubMed ID: 25553984
[TBL] [Abstract][Full Text] [Related]
2. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
3. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
6. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
Sun DK; Wang L; Wang JM; Zhang P
Genet Mol Res; 2015 Dec; 14(4):18181-7. PubMed ID: 26782465
[TBL] [Abstract][Full Text] [Related]
7. Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival.
Rochefort P; Chabaud S; Pierga JY; Tredan O; Brain E; Bidard FC; Schiffler C; Polena H; Khalil-Mgharbel A; Vilgrain I; Bachelot T
Br J Cancer; 2017 Jan; 116(3):356-361. PubMed ID: 28056463
[TBL] [Abstract][Full Text] [Related]
8. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma.
Chung Y; Law S; Kwong DL; Luk JM
Dis Esophagus; 2011 Jan; 24(1):49-55. PubMed ID: 20807231
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.
Syrigos KN; Harrington KJ; Karayiannakis AJ; Baibas N; Katirtzoglou N; Roussou P
Anticancer Res; 2004; 24(3b):2027-31. PubMed ID: 15274395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.
Charalabopoulos K; Gogali A; Dalavaga Y; Daskalopoulos G; Vassiliou M; Bablekos G; Karakosta A; Constantopoulos S
Exp Oncol; 2006 Mar; 28(1):83-5. PubMed ID: 16614715
[TBL] [Abstract][Full Text] [Related]
14. Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer.
Zhou SJ; Zhuo SR; Yang XQ; Qin CX; Wang ZL
Diagn Pathol; 2014 Aug; 9():161. PubMed ID: 25116444
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
Song CG; Wu XY; Wang C; Fu FM; Shao ZM
Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer.
Knudsen KA; Lin CY; Johnson KR; Wheelock MJ; Keshgegian AA; Soler AP
Hum Pathol; 2000 Aug; 31(8):961-5. PubMed ID: 10987257
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women.
Li XY; Tang SH; Zhou XC; Ye YH; Xu XQ; Li RZ
Peptides; 2014 Jan; 51():86-90. PubMed ID: 24269296
[TBL] [Abstract][Full Text] [Related]
18. Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma.
Tsalikidis C; Papachristou F; Pitiakoudis M; Asimakopoulos B; Trypsianis G; Bolanaki E; Syrigos KN; Simopoulos C
Folia Med (Plovdiv); 2013; 55(3-4):26-32. PubMed ID: 24712279
[TBL] [Abstract][Full Text] [Related]
19. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
